Sfoglia per AUTORE
DI SAPIO A
Collezione AOU San Luigi di Orbassano

  

Items : 32

Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA). in Journal of neurology / J Neurol. 2024 Oct;271(10):6801-6810. doi: 10.1007/s00415-024-12621-9. Epub 2024 Aug 27.
2024
AOU San Luigi di Orbassano

Chisari CG; Amato MP; Di Sapio A; Foschi M; Iaffaldano P; Inglese M; Fermo SL; Lugaresi A; Lus G; Mascoli N; Montepietra S; Pesci I; Quatrale R; Salemi G; Torri Clerici V; Totaro R; Valentino P; Filippi M; Patti F;

Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project. in Neurology and therapy / Neurol Ther. 2024 Oct;13(5):1415-1430. doi: 10.1007/s40120-024-00644-3. Epub 2024 Aug 2.
2024
AOU San Luigi di Orbassano

Paolicelli D; Borriello G; Clerici R; Colombo E; Croce D; D'Amico E; De Rossi N; Di Sapio A; Fenu G; Maimone D; Marfia GA; Moccia M; Perini P; Piscaglia MG; Razzolini L; Riccaboni M; Signoriello E; Agostoni G; Farina A; Mondino M; Berruto F; Tettamanti A; Donnaloja F; Tortorella C;

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry. in Journal of neurology / J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ferraro D; Gasperini C; Salemi G; Bergamaschi R; Lus G; Inglese M; Romano S; Bellantonio P; Di Monte E; Maniscalco GT; Conte A; Lugaresi A; Trojano M; Filippi M; Amato MP; Nica M; Ragonese P; Ruggieri S; Carotenuto A; Tortorella C; Fenu G; Onofrj M; Portaccio E; Chisari CG; Rocca MA; Ardito B; Banfi P; Nasuelli D; Paolicelli D; et alii...

Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study. in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7.
2024
AOU San Luigi di Orbassano

Chisari CG; Aguglia U; Amato MP; Bergamaschi R; Bertolotto A; Bonavita S; Morra VB; Cavalla P; Cocco E; Conte A; Cottone S; De Luca G; Di Sapio A; Filippi M; Gallo A; Gasperini C; Granella F; Lus G; Maimone D; Maniscalco GT; Marfia G; Moiola L; Paolicelli D; Pesci I; Ragonese P; Rovaris M; Salemi G; Solaro C; Totaro R; et alii...

2024
AOU San Luigi di Orbassano

Maida E; Moccia M; Palladino R; Borriello G; Affinito G; Clerico M; Repice AM; Di Sapio A; Iodice R; Spiezia AL; Sparaco M; Miele G; Bile F; Scandurra C; Ferraro D; Stromillo ML; Docimo R; De Martino A; Mancinelli L; Abbadessa G; Smolik K; Lorusso L; Leone M; Leveraro E; Lauro F; Trojsi F; Streito LM; Gabriele F; Marinelli F; et alii...

Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2024 Feb;82:105412. doi: 10.1016/j.msard.2023.105412. Epub 2023 Dec 26.
2024
AOU San Luigi di Orbassano

Vecchio D; Puricelli C; Malucchi S; Virgilio E; Martire S; Perga S; Passarelli F; Valentino P; Di Sapio A; Cantello R; Dianzani U; Comi C; Vecchio D; Puricelli C; Malucchi S; Virgilio E; Martire S; Perga S; Passarelli F; Valentino P; Di Sapio A; Cantello R; Dianzani U; Comi C;

2024
AOU San Luigi di Orbassano

Malucchi S; Bava CI; Valentino P; Martire S; Lo Re M; Bertolotto A; Di Sapio A;

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2024 Aug;11(8):2008-2015. doi: 10.1002/acn3.52118. Epub 2024 Jul 5.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Brescia Morra V; Cocco E; Torri Clerici V; Spitaleri D; Clerici R; Vianello M; Quatrale R; Di Sapio A; Montepietra S; Gallo A; Bellantonio P; Gallo P; De Luca G; Cavalla P; Romano S; Granella F; Patti F; Foschi M; Inglese M; Portaccio E; Paolicelli D; Guerra T; Lucisano G; Iaffaldano P; Marfia GA; Boccia VD; Filippi M; Amato MP; Trojano M; et alii...

Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Sep;77:104893. doi: 10.1016/j.msard.2023.104893. Epub 2023 Jul 16.
2023
AOU San Luigi di Orbassano

Valentino P; Malucchi S; Bava CI; Martire S; Capobianco M; Malentacchi M; Sperli F; Oggero A; Di Sapio A; Bertolotto A;

2022
ASL Cuneo 1
AOU San Luigi di Orbassano

Bellantonio P; Totaro R; Vianello M; Cavalla P; Granella F; Di Sapio A; Bertolotto A; Maimone D; Bergamaschi R; Lus G; Solaro C; Amato MP; Rovaris M; Gasperini C; Ferrò MT; Pesci I; Aguglia U; Maniscalco GT; Sola P; Conte A; De Luca G; Cottone S; Salemi G; Lugaresi A; Inglese M; Bonavita S; Grimaldi LM; Marfia GA; Brescia Morra V; et alii...

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2020 Oct;26(12):1519-1531. doi: 10.1177/1352458519872889. Epub 2019 Oct 1.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano

Gobbi C; Uccelli A; Signori A; Amato MP; Granella F; Barilaro A; Abbadessa G; Fenu G; Brescia Morra V; Prestipino E; Sperli F; Magnani E; Lorefice L; De Angelis M; Malentacchi M; Cellerino M; Gallo A; Sacco R; Mechi C; Salemi G; Coghe G; Nozzolillo A; Malucchi S; Boffa G; Maraffi I; Maietta I; Barone S; Maniscalco GT; Di Sapio A; et alii...

Cladribine vs other drugs in MS: Merging randomized trial with real-life data. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2020 Aug 14;7(6):e878. doi: 10.1212/NXI.0000000000000878. Print 20
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sormani MP; Visconti A; Landi D; Ippolito D; Esposito S; Russo CV; Barrilà C; Barone S; Grasso R; Pontecorvo S; Di Sapio A; Stromillo ML; Cordioli C; Rasia S; Sartori A; Clerici VT; Fenu G; Cocco E; Frau J; Barcella V; Frigeni B; La Gioia S; Pareja-Gutierrez L; Laroni A; Zarbo IR; Lavorgna L; Bonavita S; Perini P; Mataluni G; et alii...

First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Jul;42:102059. doi: 10.1016/j.msard.2020.102059. Epub 2020 Mar 16.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Signori A; Sormani MP; Carmisciano L; Turano G; Ippolito D; Russo CV; Frigeni B; Landi D; Barrilà C; Barone S; Lavorgna L; Grasso R; Di Sapio A; Cerqua R; Pontecorvo S; Stromillo ML; Cordioli C; Signoriello E; Rasia S; Sartori A; Zarbo IR; Laroni A; Frau J; Cocco E; Torri Clerici V; La Gioia S; Gutierrez LP; Clerico M; Mataluni G; et alii...

Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2017 May;14:51-55. doi: 10.1016/j.msard.2017.03.008. Epub 2017 Mar 23.
2017
AOU San Luigi di Orbassano

Melillo F; Di Sapio A; Martire S; Malentacchi M; Matta M; Bertolotto A;

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study. in Neurology and therapy / Neurol Ther. 2017 Jun;6(1):145-152. doi: 10.1007/s40120-016-0058-0. Epub 2016 Dec 3.
2017
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Lo Re M; Malentacchi M; di Sapio A; Matta M; Sperli F; Bertolotto A;

2016
AOU San Luigi di Orbassano

Troni W; Melillo F; Bertolotto A; Malucchi S; Capobianco M; Sperli F; Di Sapio A;

2015
AOU San Luigi di Orbassano

Capobianco M; di Sapio A; Malentacchi M; Malucchi S; Matta M; Sperli F; Bertolotto A;

Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-? Therapy. in Neurology and therapy / Neurol Ther. 2015 Jun;4(1):53-60. doi: 10.1007/s40120-015-0027-z. Epub 2015 Mar 6.
2015
AOU San Luigi di Orbassano

Motuzova Y; Di Sapio A; Capobianco M; Sala A; Marnetto F; Malucchi S; Bertolotto A;

Biological monitoring of IFN-? therapy in Multiple Sclerosis. in Cytokine & growth factor reviews / Cytokine Growth Factor Rev. 2015 Apr;26(2):241-8. doi: 10.1016/j.cytogfr.2014.12.002. Epub 2014 Dec
2015
AOU San Luigi di Orbassano

Bertolotto A; Granieri L; Marnetto F; Valentino P; Sala A; Capobianco M; Malucchi S; Di Sapio A; Malentacchi M; Matta M; Caldano M;

A new neurophysiological approach to assess central motor conduction damage to proximal and distal muscles of lower limbs. in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology / Clin Neurophysiol. 2014 Jan;125(1):133-41. doi: 10.1016/j.clinph.2013.06.018. Epub 2013 Jul 16.
2014
AOU San Luigi di Orbassano

Di Sapio A; Bertolotto A; Melillo F; Sperli F; Malucchi S; Troni W; Di Sapio A; Bertolotto A; Melillo F; Sperli F; Malucchi S; Troni W;

Cerebrotendinous xanthomatosis: recurrence of the CYP27A1 mutation p.Arg479Cys in Sardinia. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 Aug;35(8):1303-5. doi: 10.1007/s10072-014-1696-6. Epub 2014 Mar 2.
2014
AOU San Luigi di Orbassano

Mandrile G; Gallus GN; Mura G; Di Sapio A; Sotgiu MA; Montella A; Giachino DF; Dotti MT; Ulgheri L; Federico A;

A methodological reappraisal of non invasive high voltage electrical stimulation of lumbosacral nerve roots. in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology / Clin Neurophysiol. 2011 Oct;122(10):2071-80. doi: 10.1016/j.clinph.2011.03.002. Epub 2011 Mar 31.
2011
AOU San Luigi di Orbassano

Troni W; Di Sapio A; Berra E; Duca S; Merola A; Sperli F; Bertolotto A;

One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. in Journal of neurology / J Neurol. 2011 May;258(5):895-903. doi: 10.1007/s00415-010-5844-5. Epub 2010 Dec 12.
2011
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Sala A; Capobianco M; di Sapio A; Granieri L; Bertolotto A;

Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. in PloS one / PLoS One. 2010 Jan 29;5(1):e8962. doi: 10.1371/journal.pone.0008962.
2010
AOU San Luigi di Orbassano

Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A;

Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Sep;29 Suppl 2:S227-9. doi: 10.1007/s10072-008-0945-y.
2008
AOU San Luigi di Orbassano

Capobianco M; Rizzo A; Malucchi S; Sperli F; Di Sapio A; Oggero A; Zaffaroni M; Ghezzi A; Bertolotto A;

Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. in Journal of neuroimmunology / J Neuroimmunol. 2007 Dec;192(1-2):198-205. doi: 10.1016/j.jneuroim.2007.09.025. Epub 2007 Oct 22.
2007
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Valentino P; Granieri L; Di Sapio A; Capobianco M; Sala A; Malucchi S; Kappos L; Lindberg RL; Bertolotto A;

Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2007 Aug;28(4):209-11. doi: 10.1007/s10072-007-0823-z. Epub 2007 Aug 10.
2007
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; di Sapio A; Gilli F; Sala A; Bottero R; Marnetto F; Doriguzzi Bozzo C; Bertolotto A;

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2005 Jan;158(1-2):195-203. doi: 10.1016/j.jneuroim.2004.08.006.
2005
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Di Sapio A; Capobianco M; Bertolotto A;

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.
2004
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Malucchi S; Marnetto F; Caldano M; Di Sapio A; Capobianco M; Gilli F;

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis. in Neurology / Neurology. 2004 Jun 8;62(11):2031-7. doi: 10.1212/01.wnl.0000129265.73259.9e.
2004
AOU San Luigi di Orbassano

Malucchi S; Sala A; Gilli F; Bottero R; Di Sapio A; Capobianco M; Bertolotto A;

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2003 Oct;24(3):130-3. doi: 10.1007/s10072-003-0098-y.
2003
AOU San Luigi di Orbassano

Milano E; Di Sapio A; Malucchi S; Capobianco M; Bottero R; Sala A; Gilli F; Bertolotto A;

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients. in Neurology / Neurology. 2003 Feb 25;60(4):634-9. doi: 10.1212/01.wnl.0000046662.03894.c5.
2003
AOU San Luigi di Orbassano

Bertolotto A; Gilli F; Sala A; Capobianco M; Malucchi S; Milano E; Melis F; Marnetto F; Lindberg RL; Bottero R; Di Sapio A; Giordana MT;